Clinical trial
Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients
NCT00290823 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00290823 |
|---|---|
| Title | Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients |
| Official title | Treatment of Intraparenchymal Neurocysticercosis: Effect of Increased Dosing of Corticosteroids on Seizure Frequency |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neurocysticercosis |
| Intervention type | Drug |
| Interventions | Albendazole, Dexamethasone, Omeprazole |
| Enrollment | 110 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Feb 13, 2006 |
| Last update posted | Feb 3, 2017 |
| Countries | Peru |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: